<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180930041187N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-02-05</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of two methods of intraosseous injection and lower alveolar nerve block in the first mandibular molars with irreversible pulpitis.</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of the Anesthetic Efficacy of Intraosseous Anesthesia By Quicksleeper 5 computer-controlled system Versus inferior alveolar nerve Block in first Mandibular Molars with Irreversible Pulpitis.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-02-04</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>64</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/34186</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Individuals after obtaining consent to participate in this research are divided by stratified balanced block randomization method Into four groups (A, B, C and D) with 16 people in every group.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Asymptomatic irreversible pulpitis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: For the first group (18 to 40 years old), Intraosseous injection technique  would be used to achieve primary pulpal anesthesia using a QuickSleeper 5 device  product by (Dental Hi Tec). Intervention 2: Intervention group: For the second group  (40 to 60 years old), Intraosseous injection technique  would be used to achieve primary pulpal anesthesia using a QuickSleeper 5 device  product by (Dental Hi Tec). Intervention 3: Intervention group: For the third group (18 to 40 years old), inferior alveolar nerve block technique (conventional technique) would be used to achieve primary pulpal anesthesia. Intervention 4: Intervention group: For the fourth group (40 to 60 years old), inferior alveolar nerve block technique (conventional technique) would be used to achieve primary pulpal anesthesia.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All collected deidentified individual Participant Data.

When:
Starting 3 months after publication

To whom:
Available for researchers working in academic and scientific institutions.

Conditions:
There is no limitation for what types of analyses will be used.

Where to obtain:
Saeed Gharibian / saeed.gharibian@gmail.com / 00989120236300

How to obtain:
The applicant sends a request by sending an e-mail to the above-mentioned email; after reviewing his/her request, the data file will be sent to him/her within a maximum of one month.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Saeed Gharibian bejestani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 7,Mehr Ave., bostan dovom Street., Pasdaran Street., Tehran City</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1664869593</zip>
        <telephone>+98 21 2276 3836</telephone>
        <email>saeed.gharibian@sbmu.ac.ir</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr Shiva Shojaeian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Dental school, Shahid Beheshti University,Daneshju Blv, Evin Blv, Chamran Highway</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1983963113</zip>
        <telephone>+98 21 2240 3075</telephone>
        <email>shiva_sh84@yahoo.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>The age of the patient is over 18 years and under the age of 60 years
Patient Satisfaction to enter the study
Patients have the ability to read and understand the consent and sign it
Patients should have at least one first vital mandibular molar without spontaneous pain and positive response to Electrical Pulp Tester and prolonged response to the cold test
The absence of periapical radiolucency or any periapical lesions in radiography
Patients without any systemic diseases
Absence of acute inflammation and advanced periodontal disease at the first mandibular molar and adjacent Molar and premolar teeth and injection area</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>History of any cardiovascular disease and high blood pressure
Lactate or pregnant women
Any history of alergy to anesthetic solutions
Using analgesic drugs since 12 hours before the treatment
Mobility more than 0.5 mm
Probing more than 3 mm in mesial and distal
Severe dental pain that needs emergency treatment
Non vital coronal pulp tissue
Teeth with full crown
No lip numbness after the Inferior Alveolar Nerve Block injection
No pulp exposure after removing caries
lack of cooperation or interest of patient to continue the study</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>K04.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Asymptomatic irreversible pulpitis</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: For the first group (18 to 40 years old), Intraosseous injection technique  would be used to achieve primary pulpal anesthesia using a QuickSleeper 5 device  product by (Dental Hi Tec).</i_keyword>
      <i_keyword>Intervention group: For the second group  (40 to 60 years old), Intraosseous injection technique  would be used to achieve primary pulpal anesthesia using a QuickSleeper 5 device  product by (Dental Hi Tec).</i_keyword>
      <i_keyword>Intervention group: For the third group (18 to 40 years old), inferior alveolar nerve block technique (conventional technique) would be used to achieve primary pulpal anesthesia.</i_keyword>
      <i_keyword>Intervention group: For the fourth group (40 to 60 years old), inferior alveolar nerve block technique (conventional technique) would be used to achieve primary pulpal anesthesia.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Success of the Anesthesia. Timepoint: After the Injection and during root canal therapy (RCT). Method of measurement: Vitality pulp test (Electrical pulp tester and endo ice) before RCT and questioning from patients during RCT.</prim_outcome>
      <prim_outcome>Pain during injection. Timepoint: During injection of Anesthetic solution and immediately after completion of injection. Method of measurement: Heft-parker visual Analogue Scale.</prim_outcome>
      <prim_outcome>Pain. Timepoint: Before injection (during vital pulp tests), after injection (during the evaluation of anesthesia success). Method of measurement: Heft-parker visual Analogue Scale.</prim_outcome>
      <prim_outcome>Pulse. Timepoint: Before injection , after injection. Method of measurement: Pulse-oximeter.</prim_outcome>
      <prim_outcome>Onset of Anesthesia. Timepoint: After the injection with 1-minute intervals for a period of 15 minutes. Method of measurement: Vitality pulp test (pulp tester and endo ice).</prim_outcome>
      <prim_outcome>Duration of Anesthesia. Timepoint: From the beginning to the end of the treatment session. Method of measurement: Asking from the patients.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Anxiety. Timepoint: Before injection. Method of measurement: Visual Analogue Scale for Anxiety.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Student Researcher</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2017-08-01</approval_date>
        <contact_name>Ethics Committee of the Dental Research Institute,  Shahid Beheshti University of Medical Sciences</contact_name>
        <contact_address>Shahid Beheshti University of Dental School, Daneshjoo boulevard, Shahriari square, Velenjak Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
